Literature DB >> 11322671

Relationship between age and plasma esterases.

K Abou-Hatab1, M S O'Mahony, S Patel, K Woodhouse.   

Abstract

INTRODUCTION: the older population is the most medicated. Despite high drug usage, older people are generally excluded from the research underpinning new drug development. This means that drugs are prescribed to older people with very little understanding of how they are likely to metabolize them. More research is needed to investigate the possible effects of ageing on the biotransformation of drugs. We therefore undertook a cross-sectional study examining the effect of age on the activities of benzoylcholinesterase, butyrylcholinesterase, acetylcholinesterase and aspirin esterase.
METHODS: we measured the activities of benzoylcholinesterase and butyrylcholinesterase in 70 healthy volunteers aged 18-85 years. We measured the activities of acetylcholinesterase and aspirin esterase in 43 healthy volunteers aged 18-85 years. We determined plasma activities of benzoylcholinesterase, butyrylcholinesterase, acetylcholinesterase and aspirin esterase spectrophotometrically.
RESULTS: we found no correlation between the activities of any of the enzymes measured and advancing age.
CONCLUSION: age per se is not associated with reductions in the activities of esterase enzymes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11322671     DOI: 10.1093/ageing/30.1.41

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  11 in total

Review 1.  Drug metabolism and ageing.

Authors:  M T Kinirons; M S O'Mahony
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

2.  Treating older people.

Authors:  Ken Woodhouse
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

3.  Black and non-black population: investigation of the difference in butyrylcholinesterase activity in a healthy population in Salvador, Bahia.

Authors:  Jucelino Nery da Conceição Filho; Iris Campos Dos Santos; Davi Pereira de Jesus Gonçalves; Junia Raquel Dutra Ferreira; Ana Leonor Pardo Campos Godoy
Journal:  Ir J Med Sci       Date:  2022-07-06       Impact factor: 1.568

4.  Serum cholesterol concentration associated with aspirin esterase activity in older people: preliminary data.

Authors:  Kazuhiko Kotani; Russell Caccavello; Ricardo Hermo; Toshiyuki Yamada; Nobuyuki Taniguchi; Alejandro Gugliucci
Journal:  Int J Med Sci       Date:  2010-05-10       Impact factor: 3.738

Review 5.  Medication prescribing in frail older people.

Authors:  Ruth E Hubbard; M Sinead O'Mahony; Kenneth W Woodhouse
Journal:  Eur J Clin Pharmacol       Date:  2012-09-11       Impact factor: 2.953

6.  Plasma esterases and inflammation in ageing and frailty.

Authors:  Ruth E Hubbard; M Sinead O'Mahony; Brian L Calver; Ken W Woodhouse
Journal:  Eur J Clin Pharmacol       Date:  2008-05-28       Impact factor: 2.953

7.  Variability in the responsiveness to low-dose aspirin: pharmacological and disease-related mechanisms.

Authors:  Bianca Rocca; Giovanna Petrucci
Journal:  Thrombosis       Date:  2012-01-11

8.  Butyrylcholinesterase as a prognostic marker: a review of the literature.

Authors:  Lidia Santarpia; Ilenia Grandone; Franco Contaldo; Fabrizio Pasanisi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-09-06       Impact factor: 12.910

9.  Pseudocholinesterase levels in patients under electroconvulsive therapy.

Authors:  Gamze Küçükosman; Özcan Pişkin; Volkan Hancı; Rahşan D Okyay; Hilal Ayoğlu; Bülent S Yurtlu; Mehmet Akın; Işıl Ö Turan
Journal:  Saudi Med J       Date:  2018-01       Impact factor: 1.484

10.  Cholinesterase alterations in delirium after cardiosurgery: a German monocentric prospective study.

Authors:  Elisabeth Hannah Adam; Victoria Haas; Simone Lindau; Kai Zacharowski; Bertram Scheller
Journal:  BMJ Open       Date:  2020-01-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.